Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 Sep;62(3):633–641. doi: 10.1172/JCI109170

The Regulation of Skeletal Muscle Alanine and Glutamine Formation and Release in Experimental Chronic Uremia in the Rat

SUBSENSITIVITY OF ADENYLATE CYCLASE AND AMINO ACID RELEASE TO EPINEPHRINE AND SEROTONIN

Alan J Garber 1,2
PMCID: PMC371809  PMID: 211145

Abstract

The mechanism of the increased alanine and glutamine formation and release from skeletal muscle in experimental uremia was investigated using epitrochlearis preparations from control and chronically uremic rats. In uremic muscle, insensitivity to epinephrine or serotonin suppression of alanine and glutamine release was observed. With control muscles, 1 nm or greater, epinephrine inhibited alanine and glutamine release, whereas with uremic muscles, epinephrine concentrations <1 μM did not alter amino acid release. Decreased alanine and glutamine release with 1 nM serotonin was observed in control muscles, but no inhibition was observed with concentrations <1 μM in uremic muscle. Muscle amino acid levels were the same in control and uremic muscles in the presence or absence of epinephrine or serotonin. The reutilization of released alanine by protein synthesis or oxidation to CO2 was not differentially affected by epinephrine in uremic muscles as compared with control muscle. Dibutyryl-cAMP inhibited amino acid release equally in uremic and control muscles. Epinephrine or serotonin increased cAMP levels two- to four-fold or more in control than in uremic muscle. Basal- and fluoride-stimulated adenylate cyclase activities were equal in uremic and control muscle homogenates and in membrane fractions, but 10 μM epinephrine-stimulated adenylate cyclase was reduced 30-60% with uremia. At any concentration of epinephrine (0.001—100 μM), the stimulation of membrane adenylate cyclase activity was one- to twofold greater with control membranes than with uremic muscle membranes. With either control or uremic muscle, peak adenylate cyclase activity was observed at 1 μM epinephrine.

These data indicate that skeletal muscle in chronic uremia acquires an insensitivity to the metabolic action of epinephrine or serotonin. This insensitivity may be attributable in part to the diminished increments in muscle cAMP levels produced by adrenergic and serotonergic agonists. The decreased cAMP levels may derive in turn from a decreased activity or subsensitization of the agonist-stimulated adenylate cyclase in uremic muscle.

Full text

PDF
633

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aurbach G. D., Fedak S. A., Woodard C. J., Palmer J. S., Hauser D., Troxler F. Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site. Science. 1974 Dec 27;186(4170):1223–1224. doi: 10.1126/science.186.4170.1223. [DOI] [PubMed] [Google Scholar]
  2. Aviram A., Peters J. H., Gulyassy P. F. Dialysance of amino acids and related substances. Nephron. 1971;8(5):440–454. doi: 10.1159/000179948. [DOI] [PubMed] [Google Scholar]
  3. Bilbrey G. L., Faloona G. R., White M. G., Knochel J. P. Hyperglucagonemia of renal failure. J Clin Invest. 1974 Mar;53(3):841–847. doi: 10.1172/JCI107624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Birnbaumer L., Nakahara T., Yang P. C. Studies on receptor-mediated activation of adenylyl cyclases. II. Nucleotide and nucleoside regulation of the activities of the beef renal medullary adenylyl cyclase and their stimulation by neurohypophyseal hormones. J Biol Chem. 1974 Dec 25;249(24):7857–7866. [PubMed] [Google Scholar]
  5. Cahill G. F., Jr The Banting Memorial Lecture 1971. Physiology of insulin in man. Diabetes. 1971 Dec;20(12):785–799. doi: 10.2337/diab.20.12.785. [DOI] [PubMed] [Google Scholar]
  6. DeFronzo R. A., Andres R., Edgar P., Walker W. G. Carbohydrate metabolism in uremia: a review. Medicine (Baltimore) 1973 Sep;52(5):469–481. doi: 10.1097/00005792-197309000-00009. [DOI] [PubMed] [Google Scholar]
  7. Ganda O. P., Aoki T. T., Soeldner J. S., Morrison R. S., Cahill G. F., Jr Hormone-fuel concentrations in anephric subjects. Effect of hemodialysis (with special reference to amino acids). J Clin Invest. 1976 Jun;57(6):1403–1411. doi: 10.1172/JCI108409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Garber A. J., Bier D. M., Cryer P. E., Pagliara A. S. Hypoglycemia in compensated chronic renal insufficiency. Substrate limitation of gluconeogenesis. Diabetes. 1974 Dec;23(12):982–986. doi: 10.2337/diab.23.12.982. [DOI] [PubMed] [Google Scholar]
  9. Garber A. J., Cryer P. E., Santiago J. V., Haymond M. W., Pagliara A. S., Kipnis D. M. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest. 1976 Jul;58(1):7–15. doi: 10.1172/JCI108460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Garber A. J. Inhibition of serotonin of amino acid release and protein degradation in skeletal muscle. Mol Pharmacol. 1977 Jul;13(4):640–651. [PubMed] [Google Scholar]
  11. Garber A. J., Karl I. E., Kipnis D. M. Alanine and glutamine synthesis and release from skeletal muscle. I. Glycolysis and amino acid release. J Biol Chem. 1976 Feb 10;251(3):826–835. [PubMed] [Google Scholar]
  12. Garber A. J., Karl I. E., Kipnis D. M. Alanine and glutamine synthesis and release from skeletal muscle. IV. beta-Adrenergic inhibition of amino acid release. J Biol Chem. 1976 Feb 10;251(3):851–857. [PubMed] [Google Scholar]
  13. Garber A. J. Skeletal muscle protein and amino acid metabolism in experimental chronic uremia in the rat: accelerated alanine and glutamine formation and release. J Clin Invest. 1978 Sep;62(3):623–632. doi: 10.1172/JCI109169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gulyassy P. F., Aviram A., Peters J. H. Evaluation of amino acid and protein requirements in chronic uremia. Arch Intern Med. 1970 Nov;126(5):855–859. [PubMed] [Google Scholar]
  15. Hampers C. L., Lowrie E. G., Soeldner J. S., Merrill J. P. The effect of uremia upon glucose metabolism. Arch Intern Med. 1970 Nov;126(5):870–874. [PubMed] [Google Scholar]
  16. Jefferson L. S., Rannels D. E., Munger B. L., Morgan H. E. Insulin in the regulation of protein turnover in heart and skeletal muscle. Fed Proc. 1974 Apr;33(4):1098–1104. [PubMed] [Google Scholar]
  17. Karl I. E., Pagliara A. S., Kipnis D. M. A microfluorometric enzymatic assay for the determination of alanine and pyruvate in plasma and tissues. J Lab Clin Med. 1972 Sep;80(3):434–441. [PubMed] [Google Scholar]
  18. Kopple J. D., Swendseid M. E., Shinaberger J. H., Umezawa C. Y. The free and bound amino acids removed by hemodialysis. Trans Am Soc Artif Intern Organs. 1973;19:309–313. doi: 10.1097/00002480-197301900-00052. [DOI] [PubMed] [Google Scholar]
  19. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  20. Mickey J., Tate R., Lefkowitz R. J. Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro. J Biol Chem. 1975 Jul 25;250(14):5727–5729. [PubMed] [Google Scholar]
  21. Mukherjee C., Caron M. G., Lefkowitz R. J. Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites. Proc Natl Acad Sci U S A. 1975 May;72(5):1945–1949. doi: 10.1073/pnas.72.5.1945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nitzan M. Abnormalities of carbohydrate and lipid metabolism in experimentally induced acute uremia. Nutr Metab. 1973;15(3):187–191. doi: 10.1159/000175439. [DOI] [PubMed] [Google Scholar]
  23. Rubenfeld S., Garber A. J. Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal. J Clin Invest. 1978 Jul;62(1):20–28. doi: 10.1172/JCI109107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ruderman N. B., Berger M. The formation of glutamine and alanine in skeletal muscle. J Biol Chem. 1974 Sep 10;249(17):5500–5506. [PubMed] [Google Scholar]
  25. Russell J. E., Avioli L. V. Effect of experimental chronic renal insufficiency on bone mineral and collagen maturation. J Clin Invest. 1972 Dec;51(12):3072–3079. doi: 10.1172/JCI107134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  27. Steiner A. L., Parker C. W., Kipnis D. M. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem. 1972 Feb 25;247(4):1106–1113. [PubMed] [Google Scholar]
  28. Swenson R. S., Weisinger J., Reaven G. M. Evidence that hemodialysis does not improve the glucose tolerance of patients with chronic renal failure. Metabolism. 1974 Oct;23(10):929–936. doi: 10.1016/0026-0495(74)90042-0. [DOI] [PubMed] [Google Scholar]
  29. Weisinger J., Swenson R. S., Greene W., Taylor J. B., Reaven G. M. Comparison of the effects of metabolic acidosis and acute uremia on carbohydrate tolerance. Diabetes. 1972 Nov;21(11):1109–1115. doi: 10.2337/diab.21.11.1109. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES